TW200619228A - Immunogenic compositions of staphylococcus epidermidis polypeptide antigens - Google Patents
Immunogenic compositions of staphylococcus epidermidis polypeptide antigensInfo
- Publication number
- TW200619228A TW200619228A TW094136450A TW94136450A TW200619228A TW 200619228 A TW200619228 A TW 200619228A TW 094136450 A TW094136450 A TW 094136450A TW 94136450 A TW94136450 A TW 94136450A TW 200619228 A TW200619228 A TW 200619228A
- Authority
- TW
- Taiwan
- Prior art keywords
- staphylococcus epidermidis
- immunogenic compositions
- relates
- polypeptide antigens
- epidermidis polypeptide
- Prior art date
Links
- 241000191963 Staphylococcus epidermidis Species 0.000 title abstract 6
- 230000002163 immunogen Effects 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 4
- 229920001184 polypeptide Polymers 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 102000040430 polynucleotide Human genes 0.000 abstract 2
- 108091033319 polynucleotide Proteins 0.000 abstract 2
- 239000002157 polynucleotide Substances 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 241000191967 Staphylococcus aureus Species 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56938—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/305—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F)
- G01N2333/31—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62078804P | 2004-10-21 | 2004-10-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200619228A true TW200619228A (en) | 2006-06-16 |
Family
ID=37595601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW094136450A TW200619228A (en) | 2004-10-21 | 2005-10-19 | Immunogenic compositions of staphylococcus epidermidis polypeptide antigens |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US8445000B2 (zh) |
| EP (4) | EP2213298A3 (zh) |
| JP (2) | JP2008517918A (zh) |
| KR (1) | KR20070068455A (zh) |
| CN (1) | CN101175508A (zh) |
| AR (1) | AR051826A1 (zh) |
| AU (1) | AU2005333603A1 (zh) |
| BR (1) | BRPI0516974A (zh) |
| CA (1) | CA2583121A1 (zh) |
| IL (1) | IL182546A0 (zh) |
| TW (1) | TW200619228A (zh) |
| WO (1) | WO2007001423A2 (zh) |
| ZA (1) | ZA200703274B (zh) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2468803B (en) * | 2005-05-19 | 2011-01-19 | Exocyte Ltd | Screening methods for bacterial killing |
| BRPI1013780B8 (pt) * | 2009-04-14 | 2022-10-04 | Novartis Ag | Composição imunogênica útil para imunização contra staphylococcus aureus, seu método de preparação e composição farmacêutica |
| TWI469789B (zh) | 2009-06-22 | 2015-01-21 | Wyeth Llc | 金黃色葡萄球菌抗原之免疫原性組合物 |
| WO2011029034A2 (en) * | 2009-09-04 | 2011-03-10 | Intelligent Medical Devices, Inc. | Optimized probes and primers and methods of using same for the detection, screening, isolation and sequencing of vancomycin resistance genes and vancomycin resistant enterococci |
| EP3424495A1 (en) | 2011-07-06 | 2019-01-09 | GlaxoSmithKline Biologicals S.A. | Oil-in-water emulsions that contain nucleic acids |
| RU2649133C2 (ru) | 2011-07-06 | 2018-03-29 | Новартис Аг | Катионные эмульсии масло-в-воде |
| US20150202277A1 (en) * | 2012-08-31 | 2015-07-23 | Novartis Ag | Stabilised proteins for immunising against staphylococcus aureus |
| KR102027429B1 (ko) * | 2014-03-26 | 2019-10-01 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 돌연변이 스태필로코쿠스 항원 |
| MX2019004539A (es) * | 2016-10-21 | 2019-06-12 | Socpra Sciences Et Genie Sec | Constructos de vacuna y sus usos contra infecciones causadas por staphylococcus. |
| KR102627009B1 (ko) * | 2021-12-17 | 2024-01-19 | (주)메디톡스 | 피부 유해 세균에 대한 항세균 활성을 갖는 세균 균주, 및 이를 포함하는 약제학적 조성물 |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA811368B (en) | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
| US4837151A (en) | 1980-05-19 | 1989-06-06 | The Board Of Trustees Of The Leland Stanford Junior University, Stanford University | Live vaccines comprising two mutations and foreign antigen |
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US5078996A (en) | 1985-08-16 | 1992-01-07 | Immunex Corporation | Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor |
| DE122007000007I2 (de) | 1986-04-09 | 2010-12-30 | Genzyme Corp | Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| US4873316A (en) | 1987-06-23 | 1989-10-10 | Biogen, Inc. | Isolation of exogenous recombinant proteins from the milk of transgenic mammals |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| IL101715A (en) | 1991-05-02 | 2005-06-19 | Amgen Inc | Recombinant dna-derived cholera toxin subunit analogs |
| DK0648127T3 (da) | 1991-11-22 | 2003-05-19 | Univax Biolog Inc | Type I- og type II-overfladeantigener associeret med Staphylococcus epidermidis |
| US5769047A (en) | 1991-12-23 | 1998-06-23 | Zoche; Michael | Engine with oil separator |
| JP4124816B2 (ja) | 1992-03-19 | 2008-07-23 | ヘンリー エム．ジャクソン ファウンデーション フォー ザ アドバンスメント オブ ミリタリー メディスン | 通常のスタフィロコーカス抗原と反応する広い反応性のオプソニン抗体 |
| US5593972A (en) | 1993-01-26 | 1997-01-14 | The Wistar Institute | Genetic immunization |
| AU675702B2 (en) * | 1993-01-26 | 1997-02-13 | Leslie R. Coney | Compositions and methods for delivery of genetic material |
| IL112820A0 (en) | 1994-03-07 | 1995-05-26 | Merck & Co Inc | Coordinate in vivo gene expression |
| US6995008B1 (en) | 1994-03-07 | 2006-02-07 | Merck & Co., Inc. | Coordinate in vivo gene expression |
| US5571515A (en) | 1994-04-18 | 1996-11-05 | The Wistar Institute Of Anatomy & Biology | Compositions and methods for use of IL-12 as an adjuvant |
| US5505947A (en) | 1994-05-27 | 1996-04-09 | The University Of North Carolina At Chapel Hill | Attenuating mutations in Venezuelan Equine Encephalitis virus |
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| ES2169153T3 (es) * | 1994-09-21 | 2002-07-01 | Jackson H M Found Military Med | Anticuerpos opsonicos ampliamente reactivos que reaccionan con antigenos estafilococicos comunes. |
| US5837533A (en) | 1994-09-28 | 1998-11-17 | American Home Products Corporation | Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent |
| US7153510B1 (en) | 1995-05-04 | 2006-12-26 | Yale University | Recombinant vesiculoviruses and their uses |
| JPH11514870A (ja) | 1995-10-16 | 1999-12-21 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 新規な唾液結合タンパク質 |
| US6168918B1 (en) | 1996-01-31 | 2001-01-02 | American Home Products Corp. | Method of detecting foreign DNA integrated in eukaryotic chromosomes |
| US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
| US7060458B1 (en) * | 1997-08-14 | 2006-06-13 | Wyeth | Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
| US6380370B1 (en) * | 1997-08-14 | 2002-04-30 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
| CN1283798C (zh) | 1998-08-31 | 2006-11-08 | 都柏林伊丽莎白女皇神学院 | 凝固酶阴性葡萄球菌的多肽及多核苷酸 |
| BR9914160A (pt) | 1998-09-30 | 2001-06-26 | American Cyanamid Co | Composição antigênica, método para aumentar a capacidade de uma composição antigênica que contenha um antìgeno selecionado de uma bactéria, vìrus, fungo ou parasita patogênicos, do haemophilus influenzae, do helicobacter pylori, do vìrus sincicial respiratório, do rotavìrus, e, do vìrus simples do herpes para evocar a resposta imune de um hospedeiro vertebrado, plasmìdeo, célula hospedeira, método para produzir uma holotoxina do cólera mutante imunogênica, e, uso de uma quantidade auxiliar eficaz de uma holotoxina do cólera mutante |
| US6703492B1 (en) | 1999-11-09 | 2004-03-09 | Smithkline Beecham Corporation | Staphylococcus epidermidis nucleic acids and proteins |
| WO2001034809A2 (en) | 1999-11-09 | 2001-05-17 | Glaxo Group Limited | Staphylococcus epidermidis nucleic acids and proteins |
| GB0014907D0 (en) | 2000-06-20 | 2000-08-09 | Univ Sheffield | Antigenic polypeptides |
| AT410798B (de) | 2001-01-26 | 2003-07-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen |
| WO2002074324A1 (en) * | 2001-03-15 | 2002-09-26 | The Texas A & M University System | Collagen-binding adhesin from staphylococcus epidermidis and method of use |
| AU2002346249B2 (en) | 2001-06-07 | 2007-03-15 | The Regents Of The University Of Colorado | Mutant Forms of Cholera Holotoxin as an Adjuvant |
| MXPA03011135A (es) | 2001-06-07 | 2004-09-08 | Wyeth Corp | Formas mutantes de holotoxina de colera como adyuvante. |
| CA2808598A1 (en) | 2001-08-02 | 2003-02-13 | University Of Sheffield | Antigenic polypeptides |
| WO2004043405A2 (en) * | 2002-11-12 | 2004-05-27 | The Brigham And Women's Hospital, Inc. | Polysaccharide vaccine for staphylococcal infections |
| US20060251675A1 (en) | 2003-03-17 | 2006-11-09 | Michael Hagen | Mutant cholera holotoxin as an adjuvant and an antigen carrier protein |
| CA2520868A1 (en) * | 2003-03-31 | 2004-10-14 | Intercell Ag | Staphylococcus epidermidis antigens |
| MX2007003402A (es) * | 2004-09-22 | 2007-05-10 | Glaxosmithkline Biolog Sa | Composicion inmunogena para su uso en vacunacion contra estafilococos. |
| EP2374887A3 (en) | 2005-03-25 | 2012-07-18 | National Research Council Of Canada | Method for isolation of soluble polypeptides |
-
2005
- 2005-10-19 CA CA002583121A patent/CA2583121A1/en not_active Abandoned
- 2005-10-19 AU AU2005333603A patent/AU2005333603A1/en not_active Abandoned
- 2005-10-19 EP EP09008910A patent/EP2213298A3/en not_active Withdrawn
- 2005-10-19 US US11/665,940 patent/US8445000B2/en not_active Expired - Fee Related
- 2005-10-19 BR BRPI0516974-7A patent/BRPI0516974A/pt not_active IP Right Cessation
- 2005-10-19 CN CNA2005800360186A patent/CN101175508A/zh active Pending
- 2005-10-19 EP EP05858253A patent/EP1802335A2/en not_active Withdrawn
- 2005-10-19 EP EP10182797A patent/EP2298341A3/en not_active Withdrawn
- 2005-10-19 TW TW094136450A patent/TW200619228A/zh unknown
- 2005-10-19 JP JP2007538033A patent/JP2008517918A/ja active Pending
- 2005-10-19 KR KR1020077011032A patent/KR20070068455A/ko not_active Application Discontinuation
- 2005-10-19 WO PCT/US2005/037746 patent/WO2007001423A2/en active Application Filing
- 2005-10-19 EP EP10182802A patent/EP2340848A3/en not_active Withdrawn
- 2005-10-20 AR ARP050104384A patent/AR051826A1/es unknown
-
2007
- 2007-04-12 IL IL182546A patent/IL182546A0/en unknown
- 2007-04-20 ZA ZA200703274A patent/ZA200703274B/xx unknown
-
2013
- 2013-02-06 JP JP2013021337A patent/JP2013121981A/ja active Pending
- 2013-04-19 US US13/866,288 patent/US20130209501A1/en not_active Abandoned
-
2015
- 2015-03-31 US US14/674,512 patent/US20150196629A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007001423A2 (en) | 2007-01-04 |
| US20150196629A1 (en) | 2015-07-16 |
| EP2340848A2 (en) | 2011-07-06 |
| CA2583121A1 (en) | 2007-01-04 |
| AU2005333603A1 (en) | 2007-01-04 |
| EP2340848A3 (en) | 2011-09-14 |
| EP2213298A2 (en) | 2010-08-04 |
| BRPI0516974A (pt) | 2008-09-30 |
| US20130209501A1 (en) | 2013-08-15 |
| EP2298341A2 (en) | 2011-03-23 |
| CN101175508A (zh) | 2008-05-07 |
| WO2007001423A3 (en) | 2007-11-15 |
| US20070292450A1 (en) | 2007-12-20 |
| US8445000B2 (en) | 2013-05-21 |
| AR051826A1 (es) | 2007-02-14 |
| ZA200703274B (en) | 2008-06-25 |
| JP2008517918A (ja) | 2008-05-29 |
| EP1802335A2 (en) | 2007-07-04 |
| EP2298341A3 (en) | 2011-07-13 |
| EP2213298A3 (en) | 2011-07-20 |
| KR20070068455A (ko) | 2007-06-29 |
| IL182546A0 (en) | 2008-12-29 |
| JP2013121981A (ja) | 2013-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200619228A (en) | Immunogenic compositions of staphylococcus epidermidis polypeptide antigens | |
| MX336807B (es) | Composiciones y metodos para producir una composicion. | |
| WO2005087793A3 (en) | Immunostimulatory compositions and uses thereof | |
| WO2006017538A3 (en) | Hk1-binding proteins | |
| EP2360180A3 (en) | Pancreatic polypeptide family motifs, polypeptides and methods comprising the same | |
| MX2009010800A (es) | Composiciones inmunogenicas que comprenden polipeptidos de mycobacterium tuberculosis y fusiones de los mismos. | |
| ATE462003T1 (de) | Aus wt1 stammende krebsantigenpeptide | |
| TR201905437T4 (tr) | İki işlevli polipeptidler. | |
| WO2008079290A3 (en) | Stable buffered formulations containing polypeptides | |
| MA30153B1 (fr) | Anticorps anti-ox40l et methodes correspondantes | |
| EA200802170A1 (ru) | Лиофилизированная композиция терапевтического пептидного антитела | |
| WO2005009378A3 (en) | Polypeptides for inducing a protective immune response against staphylococcus aureus | |
| EA200702193A1 (ru) | Гликозилирование белков | |
| WO2006125201A3 (en) | Anti-biotin-pegylated-mcp-1 mutein antibodies, compositions, methods and uses | |
| WO2006060728A3 (en) | Methods and compositions involving lcrv proteins | |
| WO2007126813A3 (en) | Cross-reactive monoclonal antibodies recognizing als family proteins | |
| WO2009020553A3 (en) | Chlamydia antigens | |
| WO2005037236A3 (en) | Novel heat shock protein 20-related polypeptides and uses therefor | |
| WO2012075104A3 (en) | Novel non-primate hepacivirus | |
| WO2003093416A3 (en) | Protective antigens for the control of ixodes species infestations | |
| ATE441865T1 (de) | Neue polypeptide zur in-vintro-isolierung und vorbeugung von infektionen mit legionella pneumophila | |
| MX2010011169A (es) | Cpn10 modificada y señalizacion de prr. | |
| EP1749835A3 (en) | Protective antigens and vaccines for the control of multi species tick infestations | |
| WO2005077003A3 (en) | Pili from mycobacterium tuberculosis | |
| WO2007011776A3 (en) | Pamps, pathogen associated molecular patterns |